Protara Therapeutics, Inc. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017
Revenue & cost
Revenue -0.86M2.95M
Operating items
Research & Development 3.99M6.43M12.38M18.87M21.69M
Selling, General & Administrative 3.13M4.10M8.49M9.84M8.68M
Operating Expenses 7.12M10.53M20.87M28.70M30.36M
Operating Income -7.12M-7.58M-20.87M-28.70M-30.36M
EBIT -7.12M-7.58M-20.87M-28.70M-30.36M
Non-operating items
Interest & Investment Income 0.00M-0.86M0.14M0.19M0.26M
Other Non Operating Income 0.07M5.07M
Non Operating Income -0.79M5.07M-0.51M0.18M0.40M
Net income details
EBT -7.98M-9.29M-20.73M-28.51M-30.10M
Profit After Tax -7.91M-3.34M21.38M28.53M29.96M
Investment Income 0.01M
Income from Continuing Operations -7.98M-9.29M-20.73M-28.51M-30.10M
Consolidated Net Income -7.98M-9.29M-20.73M-28.51M-30.10M
Income towards Parent Company -7.98M-9.29M-20.73M-28.51M-30.10M
Preferred Dividend Payments 6.12M6.35M-6.75M
Net Income towards Common Stockholders -14.03M-9.70M21.38M28.53M-36.71M
Additional items
EPS (Basic) -59.66-3.1651.8768.76-83.34
Shares Outstanding (Weighted Average) 0.41M0.41M0.41M0.44M
EBITDA -7.91M-3.35M21.38M28.52M29.98M
Interest Expenses 0.86M0.86M